Abstract

BackgroundSphingosine-1-phosphate (S1P) is a bioactive metabolite of sphingolipids and produced by sphingosine kinases (SphK1 and SphK2). SphK1/S1P pathway is implicated in the progression of chronic kidney disease. However, the role of SphK1/S1P pathway in renal injury in hypertension has not been reported. This study tested the hypothesis that SphK1/S1P pathway mediates the kidney damage in DOCA-salt hypertensive mice.MethodsMale wild type (WT) C57BL6 and SphK1 knockout (KO) mice were subjected to unilateral nephrectomy, subcutaneous implant containing 50 mg of deoxycorticosterone acetate (DOCA) and 1% NaCl drinking water for 7 weeks. At the end of experiments, blood pressure data, 24 h urine and kidney samples were collected. Renal mRNA levels of SphK1 were measured by real-time RT-PCR. Markers for fibrogenesis and immune cell infiltration in kidneys were detected using Western blot and immunohistochemistray analysis, respectively. The glomerular morphological changes were examined in kidney tissue slides stained with Periodic-Acid Schiff. Four groups were studied: wild type control (WT-C), WT-DOCA, KO-C and KO-DOCA.ResultsThe renal SphK1 mRNA expression was significantly upregulated in WT-DOCA mice, whereas this upregulation of renal SphK1 mRNA was blocked in KO-DOCA mice. There was no difference in DOCA-salt-induced hypertension between WT and KO mice. The urinary albumin was increased in both DOCA-salt groups. However, the albuminuria was significantly lower in KO-DOCA than in WT-DOCA group. There were increases in glomerulosclerosis indices in both DOCA-salt groups, whereas the increases were also significantly lower in KO-DOCA than in WT-DOCA mice. Renal protein levels of α-smooth muscle actin were upregulated in both DOCA-salt groups, but the increase was significant lower in KO-DOCA than in WT-DOCA group. The increased staining areas of collagen detected by Sirius Red-staining in kidney tissue sections were also attenuated in KO-DOCA compared with WT-DOCA mice. In contrast, the increased infiltration of CD43+ (a T cell marker) or CD68+ (a macrophage marker) cells in DOCA-salt kidneys showed no significant difference between WT-DOCA and KO-DOCA mice.ConclusionsSphK1/S1P signaling pathway mediates kidney damage in DOCA-salt hypertensive mice independent of blood pressure and immune modulation.

Highlights

  • Sphingosine-1-phosphate (S1P) is a bioactive metabolite of sphingolipids and produced by sphingosine kinases (SphK1 and SphK2)

  • Urine collection, showed very similar pattern among different groups. These results demonstrated that SphK1 gene deletion attenuated deoxycorticosterone acetate (DOCA)-saltinduced kidney damage. This protection by SphK1 gene KO appeared independent of hypertension, because the Enhanced expression of SphK1 mRNA in kidneys in DOCA-salt model The relative mRNA levels of renal SphK1 was significantly elevated by 10 fold in wild type (WT)-DOCA compared with wild type control (WT-C) mice, whereas the mRNA levels of SphK1 mRNA was nearly undetectable in either KO control (KO-C) or KO DOCA-salt (KO-DOCA) kidneys (Fig. 1)

  • These data demonstrated that the DOCA-salt treatment induced the expression of SphK1 in the kidneys, which was prevented in SphK1 KO mice

Read more

Summary

Introduction

Sphingosine-1-phosphate (S1P) is a bioactive metabolite of sphingolipids and produced by sphingosine kinases (SphK1 and SphK2). SphK1/S1P pathway is implicated in the progression of chronic kidney disease. The role of SphK1/S1P pathway in renal injury in hypertension has not been reported. Sphingosine-1-phosphate (S1P) plays important roles in many physiological or pathophysiological processes via its receptors on cell membrane or as an intracellular signaling molecule [1,2,3,4]. The S1P is produced by phosphorylation of sphingosine to S1P through sphingosine kinases (SphKs) [1,2,3]. S1P produced by SphK2 functions as an intracellular signaling molecule to generate receptorindependent effects [3, 4]. S1P produced by SphK1 acts as an extracellular signaling molecule binding to its receptors on cell membrane [4,5,6,7,8]. Evidence suggests that S1P is involved in different kidney diseases, such as acute kidney injury, glomerulonephritis, diabetic nephropathy, as well as renal fibrosis [11,12,13,14]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call